• Users Online: 54849
  • Home
  • Print this page
  • Email this page
This article has been cited by
1IL-17A Damages the Blood–Retinal Barrier through Activating the Janus Kinase 1 Pathway
Eimear M. Byrne,María Llorián-Salvador,Miao Tang,Andriana Margariti,Mei Chen,Heping Xu
Biomedicines.2021;9(7)831
[DOI]
2The use of biologics for uveitis associated with spondyloarthritis
Sruthi Arepalli,James T. Rosenbaum
Current Opinion in Rheumatology.2019;31(4)349
[DOI]
3The Protective Effect of Low Dose of Lipopolysaccharide Pretreatment on Endotoxin-Induced Uveitis in Rats Is Associated with Downregulation of CSF-1 and Upregulation of LRR-1
Yunli Ling,Jing Wang,Shuo Yu,Wenjie Li,Hong Lu
Journal of Immunology Research.2020;2020(4)1
[DOI]
4A review of investigated risk factors for developing equine recurrent uveitis
Nicole B. Kingsley,Lynne Sandmeyer,Rebecca R. Bellone
Veterinary Ophthalmology.2023;26(2)86
[DOI]
5PD-1 Targeted Nanoparticles Inhibit Activated T Cells and Alleviate Autoimmunity via Suppression of Cellular Energy Metabolism Mediated by PKM2
Zhangluxi Liu,Jing Xu,Hongxi Li,Jia Shu,Guannan Su,Chunjiang Zhou,Peizeng Yang
International Journal of Nanomedicine.2022;Volume 17(2)1711
[DOI]
6The relationship between inflammatory mediator expression in the aqueous humor and secondary glaucoma incidence after silicone oil tamponade
Zhen Liu,Gang Fu,Aihua Liu
Experimental and Therapeutic Medicine.2017;Volume 17(2)1711
[DOI]
7Pro-inflammatory cytokines in spondyloarthritis: a case-control study
Maroua Slouma,Lobna Kharrat,Aymen Tezegdenti,Rim Dhahri,Ezzeddine Ghazouani,Imen Gharsallah
Expert Review of Clinical Immunology.2024;Volume 17(2)1
[DOI]
8The current status of biological treatment for uveitis
Carla Gaggiano,Jurgen Sota,Stefano Gentileschi,Valeria Caggiano,Salvatore Grosso,Gian Marco Tosi,Bruno Frediani,Luca Cantarini,Claudia Fabiani
Expert Review of Clinical Immunology.2020;16(8)787
[DOI]
9Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk
Lucia Novelli,Ennio Lubrano,Vincenzo Venerito,Fabio Massimo Perrotta,Francesca Marando,Giacomo Curradi,Florenzo Iannone
Frontiers in Medicine.2021;8(8)787
[DOI]
10Mesenchymal stem cells moderate experimental autoimmune uveitis by dynamic regulating Th17 and Breg cells response
Yajun Mu,Wei Xu,Jue Liu,Yingwei Wang,Jian Chen,Qing Zhou
Journal of Tissue Engineering and Regenerative Medicine.2022;16(1)26
[DOI]
11DAPT reverses the Th17/Treg imbalance in experimental autoimmune uveitis in vitro via inhibiting Notch signaling pathway
Xuewei Yin,Huixia Wei,Shanshan Wu,Zhe Wang,Bin Liu,Lijie Guo,Hongsheng Bi,Dadong Guo
International Immunopharmacology.2020;79(1)106107
[DOI]
12Diagnostic and Prognostic Roles of Serum Interleukin-6 Levels in Patients with Uveitis
Arash Maleki,Sebastian Gomez,Soheila Asgari,Zoe Bosenberg,Ambika Manhapra,Marisa Walsh,Angelina Weng,Catherine Tsang,Celestine He,Stephen Damien Anesi,C. Stephen Foster
Ocular Immunology and Inflammation.2022;30(2)457
[DOI]
13Activation of the Notch signaling pathway disturbs the CD4+/CD8+, Th17/Treg balance in rats with experimental autoimmune uveitis
Xuewei Yin,Bin Liu,Huixia Wei,Shanshan Wu,Lijie Guo,Furu Xu,TingTing Liu,Hongsheng Bi,Dadong Guo
Inflammation Research.2019;68(9)761
[DOI]
14Inhibition ofFAAHsuppressesRANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss partially through repressing theIL17pathway
Meipeng Zhu,Qian Guo,Honglei Kang,Renpeng Peng,Yimin Dong,Yayun Zhang,Sibo Wang,Haiyang Liu,Hongjian Zhao,Zijian Dong,Kehan Song,Shimeng Xu,Pengju Wang,Liangxi Chen,Jian Liu,Feng Li
The FASEB Journal.2023;37(1)761
[DOI]
15Emerging Treatments for Non-infectious Uveitis
Alay S Banker,Carlos Pavesio,Pauline Merrill
US Ophthalmic Review.2018;11(2)81
[DOI]
16Regulatory T cells and IL-17A levels in noninfectious uveitis
Marta Catarina Esteves Guedes,Maria Jorge Arroz,Catarina Martins,Miguel Angelo-Dias,Rui Daniel Proença,Luis Miguel Borrego
Graefe's Archive for Clinical and Experimental Ophthalmology.2020;258(6)1269
[DOI]
17Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials
Zheng Xian Thng,Albert John Bromeo,S. Saeed Mohammadi,Anadi Khatri,Anh N.T. Tran,Amir Akhavanrezayat,Ngoc T.T. Than,Khiem S. Nguyen,Woong-Sun Yoo,Azadeh Mobasserian,Christopher Chi Mong Or,Quan Dong Nguyen
Expert Opinion on Emerging Drugs.2023;28(4)297
[DOI]
18Potential Interplay between Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy
François Willermain,Lisa Scifo,Célia Weber,Laure Caspers,Jason Perret,Christine Delporte
International Journal of Molecular Sciences.2018;19(4)1056
[DOI]
19Protective role of IL-17-producing ?d T cells in a laser-induced choroidal neovascularization mouse model
Yu-Hsien Chang,Chung-Hsi Hsing,Chiao-Juno Chiu,Yi-Rou Wu,Sheng-Min Hsu,Yu-Hsiang Hsu
Journal of Neuroinflammation.2023;20(1)1056
[DOI]
20Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation
Wei Cheng Liang,Jia Lin Ren,Qiu Xiao Yu,Jian Li,Tsz Kin Ng,Wai Kit Chu,Yong Jie Qin,Kai On Chu,Andrew V. Schally,Chi Pui Pang,Sun On Chan
Proceedings of the National Academy of Sciences.2020;117(11)6067
[DOI]
21The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases
S.P. Déo-Gracias Berry,Camille Dossou,Ali Kashif,Niusha Sharifinejad,Gholamreza Azizi,Haleh Hamedifar,Araz Sabzvari,Zeineb Zian
International Immunopharmacology.2022;102(11)108402
[DOI]
22Behçet’s disease and uveitis
I.Yu. Razumova,A.A. Godzenko
Vestnik oftal'mologii.2021;137(5)130
[DOI]
23New possibilities in therapy of ocular inflammation in rheumatic diseases
I.Yu. Razumova,A.A. Godzenko
Vestnik oftal'mologii.2022;138(6)108
[DOI]
24Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-a inhibition: a narrative review
Carla Gaggiano,Donato Rigante,Gian Marco Tosi,Antonio Vitale,Bruno Frediani,Salvatore Grosso,Claudia Fabiani,Luca Cantarini
Clinical Rheumatology.2020;39(2)327
[DOI]
25Interleukin-17A Interweaves the Skeletal and Immune Systems
Mengjia Tang,Lingyun Lu,Xijie Yu
Frontiers in Immunology.2021;11(2)327
[DOI]
26Pediatric Noninfectious Uveitis Medical Treatment Update
Monique Munro,Ann-Marie Lobo,Pooja Bhat
Advances in Ophthalmology and Optometry.2020;5(2)331
[DOI]
27The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases
Alexa DeMaio,Shikhar Mehrotra,Kumar Sambamurti,Shahid Husain
Journal of Neuroinflammation.2022;19(1)331
[DOI]
28The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases
Ashvini Reddy,Fauziyya Muhammad,Darren J. Lee
Journal of Neuroinflammation.2019;19(1)331
[DOI]
29Current Knowledge of Biologics in Treatment of Noninfectious Uveitis
Simple Gupta,K. Shyamsundar,Mohini Agrawal,Nitin Vichare,Jyotirmay Biswas
Journal of Ocular Pharmacology and Therapeutics.2022;38(3)203
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal